Ovarian cancer metastasis study identifies important protein with...
Advanced ovarian cancer most commonly metastasizes to the omentum, a layer of fatty tissue that wraps around and protects internal...

BIA-ALCL study shows multi-team treatment key to achieving...
A team of researchers from across five disciplines at MD Anderson recently published the largest prospective study on breast implant...
Study shows Enhanced Recovery After Surgery lowers pain and...
MD Anderson surgeons have found a way to reduce pain and opioid use for lung cancer patients undergoing a lung...
Twelve MD Anderson researchers honored with 2020 AACR Team Science...
The American Association for Cancer Research (AACR) is recognizing the founding members of The Cancer Genome Atlas (TCGA) and the...

Brain metastases recruit suppressive immune cells via novel...
MD Anderson researchers have discovered that metastatic cancer cells in the brain upregulate expression of the EZH2 gene to activate a...
Cancer-associated fibroblasts fuel breast cancer growth
Researchers at MD Anderson have discovered that cancer-associated fibroblasts (CAF) help fuel the growth of breast tumors. Their...
ASCO: Palliative and supportive care interventions increase...
Two studies presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted MD Anderson’s commitment to...
ASCO: Updated targeted therapy clinical trials results...
Updated results from two MD Anderson clinical trials presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting...
ASCO: Developing effective combination therapies for...
Findings from three studies led by researchers at MD Anderson suggest that new combination therapies are safe and effective against...
ASCO: Advances in T cell therapies for lymphomas
Two studies led by MD Anderson researchers explore advancements in CAR T cell therapy for non-Hodgkin lymphomas. CAR T cell therapy is...
ASCO: Studies pave the way on immunotherapy clinical trials...
Several MD Anderson-led studies at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting focus on using immunotherapy...
ASCO: Emerging approaches to improve immunotherapy for...
Brian Odle has now overcome four cancer diagnoses in his life, thanks to inheriting a mutation in the TP53 gene. This inherited...
ASCO: Emerging targeted therapies show signs of clinical...
Julia Pitts tried all the standard treatment options with her local physicians after she was diagnosed with metastatic uterine cancer...
ASCO: Studies show advances in treatment and understanding...
Mutations in the BRCA 1 or 2 genes significantly increase an individual’s risk of developing breast cancer, as well as several other...
Study shows potential for digital microscopy for real-time...
Strategies to procure high-quality core-needle biopsy (CNB) specimens are critical for making basic tissue diagnoses and for ancillary...
Larotrectinib shows marked responses with NTRK gene...
In an analysis of three clinical trials, the targeted therapy larotrectinib resulted in a 79% overall response rate and median overall...
Genomic study of brain metastases sheds light on unique...
A deep sequencing study of brain metastases from MD Anderson revealed many similarities but also distinct differences relative to the...
Phase I clinical trial shows WNT974 in combination with...
An MD Anderson Phase I clinical trial demonstrated that a combination therapy using WNT974, a drug that targets the WNT pathway in...
Study shows naproxen promotes immune activation in Lynch...
A Phase I chemoprevention clinical trial led by MD Anderson researchers found that naproxen, an over-the-counter anti-inflammatory...
AACR: Ovarian cancer clinical trial shows effects, safety...
Results from a clinical trial led by MD Anderson researchers showed that combining the immunotherapy checkpoint inhibitor drug...
Ovarian cancer analysis identifies potential treatment...
MD Anderson researchers have identified potential biomarkers for the response of high-grade serous ovarian cancers (HGSC) to surgical...
Chemotherapy/immunotherapy combination thwarts glioblastoma...
Triple combination therapy kills glioblastoma in mice by putting an “eat me” signal to the immune system on the surface of the brain...
Immunotherapy combination stifles pancreatic cancer in...
Combining two immunotherapies caused tumor rejection in mouse models of pancreatic cancer and provided long-term immune memory that...
Acute myeloid leukemia’s minimal residual disease targeted...
In patients with leukemia, complete remission after treatment is currently defined by the absence of cancer cells in a bone marrow...
Triple-negative breast cancer clinical trial allies with...
Triple-negative breast cancer (TNBC) is an aggressive disease that makes up roughly 15% to 20% of breast cancer diagnoses. Standard...
Scientific communication predicts research career intention
“Trainees at the Ph.D. and postdoctoral level are leaving the academic research track at alarming rates, and disproportionately if...
For non-small cell lung cancer, T cell repertoire in lungs...
Surveying the landscape of T cell presence and activity across the lungs of patients treated for localized non-small cell lung cancer,...
New guidelines for breast implant-associated anaplastic...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon form of ALCL that was first reported in 1996. The...
Heated post-surgical chemotherapy improves survival for...
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of cancer treatment in which surgeons apply heated chemotherapy...
Extending cervical cancer prevention around the world
While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the...
Ovarian Cancer Moon Shot works to broaden immunotherapy...
Immunotherapies have brought the potential for long-term remission and even cures to patients with many cancer types, but the benefits...
Hussein Tawbi named to President’s Council on Science and...
President Donald Trump today announced his intent to appoint Hussein Tawbi, M.D., Ph.D., associate professor and deputy chairman of...
Making CAR T cell therapy more effective for B-cell...
Chimeric antigen receptor (CAR) T cells were approved by the Food and Drug Administration (FDA) to treat relapsed and refractory large...
MD Anderson accelerates cellular therapy programs by buying...
Cellular therapies have emerged as an effective new therapy for patients with certain types of cancer, and MD Anderson has played an...
Tumor cells form networks to penetrate the brain
Researchers from MD Anderson have revealed how glioma cells move and infiltrate the brain, providing a new potential treatment pathway...
JAMA study reveals side effect impact of localized prostate...
A study published in JAMA comparing adverse event outcomes by treatment type for patients with localized prostate cancer reveals...
ECLIPSE looks to extinguish leukemia by uncovering new...
MD Anderson has created a new research platform to drive the discovery of new therapeutic agents for patients with leukemia by...